Health Care & Life Sciences » Biotechnology | Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. ADR | Income Statement

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
7.00
24.00
71.00
341.00
372.00
125.70
Gross Income
7.00
24.00
71.00
341.00
372.00
125.70
SG&A Expense
3,501.00
5,525.00
10,026.00
15,883.00
24,061.00
8,009.10
EBIT
3,508.00
5,549.00
10,097.00
16,224.00
24,433.00
8,134.90
Unusual Expense
608.00
-
-
-
-
2,546.10
Non Operating Income/Expense
29.00
-
79.00
280.00
3,892.00
5.60
Interest Expense
202.00
39.00
-
33.00
-
-
Pretax Income
3,070.00
5,551.00
10,172.00
15,317.00
28,224.00
5,594.30
Consolidated Net Income
3,070.00
5,551.00
10,172.00
15,317.00
28,224.00
5,594.30
Net Income
3,070.00
5,551.00
10,172.00
15,317.00
28,224.00
5,594.30
Net Income After Extraordinaries
3,070.00
5,551.00
10,172.00
15,317.00
28,224.00
5,594.30
Net Income Available to Common
3,070.00
5,551.00
10,172.00
15,317.00
28,224.00
5,594.30
EPS (Basic)
0.06
0.08
0.14
0.17
0.25
0.86
Basic Shares Outstanding
49,152.90
65,968.80
74,475.10
91,128.50
111,968.70
6,471.30
EPS (Diluted)
0.06
0.08
0.14
0.17
0.25
0.86
Diluted Shares Outstanding
49,152.90
65,968.80
74,475.10
91,128.50
111,968.70
6,471.30
EBITDA
3,501.00
5,525.00
10,026.00
15,883.00
24,061.00
8,009.20
Non-Operating Interest Income
3.00
37.00
4.00
660.00
101.00
-

About Cellect Biotechnology

View Profile
Address
23 Hata'as Street
Kfar Saba JM 44425
Israel
Employees -
Website http://cellect.co
Updated 07/08/2019
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.